This provides a solid foundation. Good performance for the quarter and a great start to the second half of the financial year. The next quarterly will show us some evening out of expenses and allow some longer-term revenue growth. Interesting that we are pursuing TGA approval for our Focus product. It looks like FY23 is where we can expect some significant milestones. This remains a stock with great potential for gradual growth and which will reward the patient, IMO.
Ann: Appendix 4C - Quarterly Activity and Cashflow Reports, page-2
Add CCO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $17.61M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $6.374K | 783.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 15811100 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 2704379 | 3 |
View Market Depth
| Last trade - 15.58pm 11/11/2024 (20 minute delay) ? |
| CCO (ASX) Chart |